Timeliness of antibiotics for patients with sepsis and septic shock.
Antibiotics
Surviving Sepsis Campaign (SSC)
prehospital antibiotics against sepsis (PHANTASi)
sepsis
shock
Journal
Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
entrez:
10
3
2020
pubmed:
10
3
2020
medline:
10
3
2020
Statut:
ppublish
Résumé
For many years, sepsis guidelines have focused on early administration of antibiotics. While this practice may benefit some patients, for others it might have detrimental consequences. The increasingly shortened timeframes in which administration of antibiotics is recommended, have forced physicians to sacrifice diagnostic accuracy for speed, encouraging the overuse of antibiotics. The evidence supporting this practice is based on retrospective data, with all the limitations attached, while the only randomized trial on this subject does not show a mortality benefit from early administration of antibiotics in a population of patients with sepsis as often seen in the emergency department (ED). Physicians are challenged to treat patients suspected of having sepsis within a short period of time, while the real challenge should be to identify patients who would not be harmed by withholding treatment with antibiotics until the diagnosis of infection with a bacterial origin is confirmed and the appropriateness of a course of antibiotics can be evaluated more adequately. Therefore, in the general population of patients with sepsis, taking the time to gather additional data to confirm the diagnosis should be encouraged without a specific timeframe, although physicians should be encouraged to perform an adequate work-up as soon as possible. Patients with suspected sepsis and signs of shock should immediately be treated with antibiotics, as there is no margin for error.
Identifiants
pubmed: 32148927
doi: 10.21037/jtd.2019.10.35
pii: jtd-12-S1-S66
pmc: PMC7024760
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
S66-S71Informations de copyright
2020 Journal of Thoracic Disease. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of Interest: The authors have no conflicts of interest to declare.
Références
N Engl J Med. 2019 Feb 7;380(6):593-596
pubmed: 30726686
Am J Respir Crit Care Med. 2017 Oct 1;196(7):800-802
pubmed: 28504905
Kidney Int. 2008 Feb;73(3):256-60
pubmed: 17978811
Lancet Respir Med. 2018 Mar;6(3):e8
pubmed: 29508708
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Am J Respir Crit Care Med. 2017 Oct 1;196(7):856-863
pubmed: 28345952
JAMA. 2018 Oct 9;320(14):1433-1434
pubmed: 30242350
Chest. 2019 Jan;155(1):19-20
pubmed: 30616722
Am J Emerg Med. 2019 Aug;37(8):1490-1497
pubmed: 30470600
Chest. 2019 Jan;155(1):12-14
pubmed: 30616719
Crit Care Med. 2015 Sep;43(9):1907-15
pubmed: 26121073
West J Emerg Med. 2019 Mar;20(2):185-190
pubmed: 30881534
J Am Geriatr Soc. 2019 Mar;67(3):484-492
pubmed: 30467825
Am J Infect Control. 2017 Oct 1;45(10):1091-1100
pubmed: 28602274
Ann Emerg Med. 2019 Apr;73(4):356-358
pubmed: 30193754
Lancet Respir Med. 2018 Jan;6(1):40-50
pubmed: 29196046
N Engl J Med. 2017 Jun 8;376(23):2235-2244
pubmed: 28528569
Crit Care. 2015 Sep 07;19:319
pubmed: 26346055
Intensive Care Med. 2018 Jun;44(6):925-928
pubmed: 29675566
Ann Intern Med. 2018 Aug 21;169(4):264-265
pubmed: 30128520
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
Neth J Med. 2017 Jun;75(5):196-203
pubmed: 28653945
Eur J Emerg Med. 2014 Oct;21(5):330-5
pubmed: 24185258
Clin Infect Dis. 2018 May 2;66(10):1631-1635
pubmed: 29182749
Lancet Infect Dis. 2012 Oct;12(10):774-80
pubmed: 22951600
PLoS One. 2019 Mar 21;14(3):e0214052
pubmed: 30897186
Chest. 2019 Jan;155(1):17-18
pubmed: 30616721
Neth J Med. 2018 May;76(4):158-166
pubmed: 29845938
Crit Care Med. 2017 Mar;45(3):486-552
pubmed: 28098591
Crit Care. 2015 Apr 29;19:194
pubmed: 25925412